Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

BACKGROUND: Despite its recommendation by the current guidelines, the role of long-term oral beta-blocker therapy has never been evaluated by randomized trials in uncomplicated ST-segment elevation myocardial infarction (STEMI) patients without heart failure, left ventricular dysfunction or ventricu...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Hiroki, Ozasa, Neiko, Morimoto, Takeshi, Shiomi, Hiroki, Bingyuan, Bao, Suwa, Satoru, Nakagawa, Yoshihisa, Izumi, Chisato, Kadota, Kazushige, Ikeguchi, Shigeru, Hibi, Kiyoshi, Furukawa, Yutaka, Kaji, Shuichiro, Suzuki, Takahiko, Akao, Masaharu, Inada, Tsukasa, Hayashi, Yasuhiko, Nanasato, Mamoru, Okutsu, Masaaki, Kametani, Ryosuke, Sone, Takahito, Sugimura, Yoichi, Kawai, Kazuya, Abe, Mitsunori, Kaneko, Hironori, Nakamura, Sunao, Kimura, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112626/
https://www.ncbi.nlm.nih.gov/pubmed/30153268
http://dx.doi.org/10.1371/journal.pone.0199347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112626/
https://www.ncbi.nlm.nih.gov/pubmed/30153268
http://dx.doi.org/10.1371/journal.pone.0199347

Ejemplares similares